Cervical cancer in Africa, Latin America and the Caribbean and Asia: Regional inequalities and changing trends
- 10 August 2017
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 141 (10) , 1997-2001
Abstract
The vast majority (86% or 453,000 cases) of the global burden of cervical cancer occurs in Africa, Latin America and the Caribbean and Asia, where one in nine new cancer cases are of the cervix. Although the disease has become rare in high‐resource settings (e.g., in North America, parts of Europe, Japan) that have historically invested in effective screening programs, the patterns and trends are variable elsewhere. While favourable incidence trends have been recorded in many populations in Asia and Latin America and the Caribbean in the past decades, rising rates have been observed in sub‐Saharan African countries, where high quality incidence series are available. The challenge for countries heavily affected by the disease in these regions is to ensure resource‐dependent programmes of screening and vaccination are implemented to transform the situation, so that accelerated declines in cervical cancer are not the preserve of high‐income countries, but become the norm in all populations worldwide.Keywords
This publication has 18 references indexed in Scilit:
- Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017–40: a population-based studyThe Lancet Oncology, 2016
- EUROGIN 2014 roadmap: Differences in human papillomavirus infection natural history, transmission and human papillomavirus‐related cancer incidence by gender and anatomic site of infectionInternational Journal of Cancer, 2014
- 50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidenceBritish Journal of Cancer, 2014
- Worldwide trends in cervical cancer incidence: Impact of screening against changes in disease risk factorsEuropean Journal of Cancer, 2013
- Clinical trials of human papillomavirus vaccines and beyondNature Reviews Clinical Oncology, 2013
- Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical CancerVaccine, 2012
- A Review of Clinical Trials of Human Papillomavirus Prophylactic VaccinesVaccine, 2012
- Global cancer transitions according to the Human Development Index (2008–2030): a population-based studyThe Lancet Oncology, 2012
- Global burden of cancers attributable to infections in 2008: a review and synthetic analysisThe Lancet Oncology, 2012
- Human papillomavirus is a necessary cause of invasive cervical cancer worldwideThe Journal of Pathology, 1999